Trials / Unknown
UnknownNCT02688062
NeuroRegen Scaffold™ With Bone Marrow Mononuclear Cells Transplantation vs. Intradural Decompression and Adhesiolysis in SCI
NeuroRegen Scaffold™ With Bone Marrow Mononuclear Cells Transplantation vs. Intradural Decompression and Adhesiolysis in Patients With Chronic Spinal Cord Injury
- Status
- Unknown
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 22 (estimated)
- Sponsor
- Chinese Academy of Sciences · Other Government
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate the efficacy and safety of NeuroRegen Scaffold with bone marrow mononuclear cells (BMMCs) on neurological recovery following chronic and complete spinal cord injury, compared to the treatment of surgical intradural decompression and adhesiolysis only.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | NeuroRegen Scaffold with BMMCs transplantation | Patients with chronic SCI (ASIA grade A) will receive NeuroRegen Scaffold with bone marrow mononuclear cells (BMMCs) transplantation after localized scars cleared and after surgery patients will undergo a comprehensive rehabilitation, psychological and nutritional measures. |
| PROCEDURE | Surgical intradural decompression and adhesiolysis | Patients with chronic SCI (ASIA grade A) will receive intradural decompression and adhesiolysis surgery and after surgery patients will undergo a comprehensive rehabilitation, psychological and nutritional measures. |
Timeline
- Start date
- 2016-01-01
- Primary completion
- 2021-12-01
- Completion
- 2021-12-01
- First posted
- 2016-02-23
- Last updated
- 2020-12-23
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02688062. Inclusion in this directory is not an endorsement.